Skip to content

Multi-product PrEP Delivery to Young Women Seeking Reproductive Health Services and Coverage of HIV Prevention

Multi-product PrEP Delivery to Young Women Seeking Reproductive Health Services and Coverage of HIV Prevention

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07076043
Acronym
PrEMIA
Enrollment
1400
Registered
2025-07-20
Start date
2025-06-03
Completion date
2029-12-30
Last updated
2026-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hiv

Keywords

HIV prevention, PrEP, Adolescent girls and young women, Kenya, stepped wedge cluster randomized trial

Brief summary

Following on the heels of large implementation science projects that participated in the launch of widespread daily oral PrEP availability, investigators will launch and study the integration of novel PrEP products - beginning with the dapivirine ring- into existing PrEP programs that reach women seeking reproductive health care at health facilities in Kenya. Intervention delivery will be launched among 12 participating clinics with approximately 1400 AGYW seeking reproductive health services and counseled about PrEP through a stepped wedge cluster randomized trial. investigators will support participating clinics to add dapivirine ring into their existing PrEP services offered to women seeking reproductive health care. The primary aim of the study will be to determine whether the availability of multiple PrEP products to young women will result in greater frequency of PrEP initiation and persistence.

Interventions

DRUGMultiple Product PrEP Program

In the intervention phase, clinics will offer a multi-product PrEP program, which includes daily oral PrEP and other forms of PrEP that are available. To start, the dapivirine vaginal ring will be included among the other forms of PrEP that are available. Others will be added as they become available in Kenya.

DRUGRoutine Oral PrEP

Daily oral PrEP

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER
University of Washington
CollaboratorOTHER
Kenya Medical Research Institute
CollaboratorOTHER
National Institute of Mental Health (NIMH)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

for Adolescent Girls and Young Women seeking reproductive health services: Age ≥18 years and ≤30years. Seeking a reproductive health service from one of the project facilities (reproductive health services include but are not limited to family planning, maternal and child health, postnatal care). AGYW receiving reproductive health-related services through OPD, or other departments are eligible. AGYW receiving reproductive health-related services through other departments are eligible. Willing and able to partake in an informed consent process. Able to speak and read in Kiswahili or English.

Design outcomes

Primary

MeasureTime frameDescription
PrEP initiationFrom enrolment to 6 monthsWomen who start to use PrEP

Secondary

MeasureTime frameDescription
PrEP persistence at 3 monthsFrom enrolment to 3 monthsWomen who continue to use PrEP 3 months since they initiated PrEP

Countries

Kenya

Contacts

CONTACTRenee Heffron, PhD, MPH
rheffron@uabmc.edu205-934-7349
PRINCIPAL_INVESTIGATORNelly Mugo, MBChB, MMed, MPH

Kenya Medical Research Institute

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 23, 2026